Skip to main content

The Evolving Post-PCI Antithrombotic Therapies.

Publication ,  Journal Article
Ohman, EM
Published in: N Engl J Med
October 28, 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

October 28, 2021

Volume

385

Issue

18

Start / End Page

1712 / 1714

Location

United States

Related Subject Headings

  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Humans
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Anticoagulants
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ohman, E. M. (2021). The Evolving Post-PCI Antithrombotic Therapies. N Engl J Med, 385(18), 1712–1714. https://doi.org/10.1056/NEJMe2112747
Ohman, E Magnus. “The Evolving Post-PCI Antithrombotic Therapies.N Engl J Med 385, no. 18 (October 28, 2021): 1712–14. https://doi.org/10.1056/NEJMe2112747.
Ohman EM. The Evolving Post-PCI Antithrombotic Therapies. N Engl J Med. 2021 Oct 28;385(18):1712–4.
Ohman, E. Magnus. “The Evolving Post-PCI Antithrombotic Therapies.N Engl J Med, vol. 385, no. 18, Oct. 2021, pp. 1712–14. Pubmed, doi:10.1056/NEJMe2112747.
Ohman EM. The Evolving Post-PCI Antithrombotic Therapies. N Engl J Med. 2021 Oct 28;385(18):1712–1714.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

October 28, 2021

Volume

385

Issue

18

Start / End Page

1712 / 1714

Location

United States

Related Subject Headings

  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Humans
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Anticoagulants
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences